Yuji KUMAGAI
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects (NCT03055403) | Yuji KUMAGAI | 2017-02-17 |
Track Yuji KUMAGAI automatically
Every clearance here is in the API, with alerts when new ones post.